Compositions and methods for treating or limiting development of age-related macular degeneration
AssigneeArizona Board of Regents on Behalf of the University of Arizona
InventorsRobert Snyder, Brian McKay
Life of this patent
Estimating the term…
Abstract
The disclosure provides methods for treating or limiting development age-related macular degeneration, comprising (a) a GPR143 receptor agonist, including but not limited to L-DOPA, L-DOPA analogues, or a pharmaceutically acceptable salt thereof, and (b) melatonin, a melatonin analogue, or a pharmaceutically acceptable salt thereof, and related compositions.
Claims28
A method for treating or limiting development of age-related macular degeneration (AMD), comprising administering to a subject in need thereof an amount effective to treat or limit development of AMD:
- (a) a GPR143 receptor agonist;
- and
- (b) melatonin, a melatonin analogue, or a pharmaceutically acceptable salt thereof.
4-7. (canceled)
A composition comprising:
- (a) a GPR143 receptor agonist;
- (b) melatonin, a melatonin analogue, or a pharmaceutically acceptable salt thereof;
- and
- (c) a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.